Abstract
Respiratory infections are a major cause of morbidity and mortality in immunocompromised non-neutropenic patients. For some respiratory infections in this patient group, mortality exceeds 80% (for example, invasive pulmonary aspergillosis in liver transplant recipients) [1]. The incidence of respiratory infections in immunocompromised patients is considerable; 15% of solid-organ transplant recipients and greater than 50% in patients with advanced human immunodeficiency virus (HIV) infection will develop pneumonia [2].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
